Skip to main content
. 2012 May 22;55(5):737–745. doi: 10.1093/cid/cis501

Table 1.

Resistance Mutations in HIV-1 Reverse Transcriptase Associated With Failure Among Participants Treated With Efavirenz or Nevirapine and Stavudine-Lamivudine.

Domain Mutation Mutations With EFV, % (No.; n = 41)
Mutations With NVP, % (No.; n = 22)
Before Therapy At Failure P Before Therapy At Failure P
Polymerase A62V 0.0 (0) 7.3 (3) .25 0.0 (0) 0.0 (0)
K65R 0.0 (0) 4.9 (2) .50 0.0 (0) 0.0 (0)
D67N 0.0 (0) 2.4 (1) 1.0 0.0 (0) 0.0 (0)
K70R 0.0 (0) 2.4 (1) 1.0 0.0 (0) 0.0 (0)
V75I 0.0 (0) 2.4 (1) 1.0 0.0 (0) 4.5 (1) 1.0
V90I 0.0 (0) 4.9 (2) .50 0.0 (0) 0.0 (0)
A98G 0.0 (0) 0.0 (0) 0.0 (0) 4.5 (1) 1.0
K101E 2.4 (1) 12.0 (5) .22 0.0 (0) 4.5 (1) 1.0
K103N 4.9 (2) 54.0 (22) <.0001 14.0 (3) 32.0 (7) .13
V106A/I 0.0 (0) 2.4 (1) 1.0 0.0 (0) 18.0 (4) .13
V106M 0.0 (0) 22.0 (9) .004 4.5 (1) 9.0 (2) 1.0
V108I 0.0 (0) 2.4 (1) 1.0 0.0 (0) 9.0 (2) .50
V179D 2.4 (1) 4.9 (2) 1.0 0.0 (0) 0.0 (0)
Y181C 2.4 (1) 0.0 (0) 1.0 0.0 (0) 41.0 (9) .004
M184V 0.0 (0) 71.0 (29) <.0001 0.0 (0) 73.0 (16) <.0001
Y188C/H 0.0 (0) 7.3 (3) .25 0.0 (0) 0.0 (0)
G190A/S 4.9 (2) 12.0 (5) .37 0.0 (0) 9.0 (2) .50
K219E 0.0 (0) 2.4 (1) 1.0 0.0 (0) 0.0 (0)
P225H 0.0 (0) 12.0 (5) .06 0.0 (0) 0.0 (0)
M230L 0.0 (0) 4.9 (2) .50 0.0 (0) 4.5 (1) 1.0
Connection D324E 10.0 (4) 17.0 (7) .25 0.0 (0) 0.0 (0)
N348I 0.0 (0) 12.0 (5) .06 0.0 (0) 45.0 (10) .002
V365I 4.9 (2) 10.0 (4) .50 14.0 (3) 18.0 (4) 1.0
T369I 0.0 (0) 7.3 (3) .25 0.0 (0) 0.0 (0)
A371V 0.0 (0) 4.9 (2) .50 0.0 (0) 0.0 (0)
M377R 0.0 (0) 0.0 (0) 0.0 (0) 9.0 (2) .50
D404N 0.0 (0) 7.3 (3) .25 0.0 (0) 9.0 (2) .50
RNase H I452L 32.0 (13) 37.0 (15) .50 45.0 (10) 27.0 (6) .13
V467I 24.0 (10) 27.0 (11) 1.0 32.0 (7) 41.0 (9) .50
L517I 12.0 (5) 22.0 (9) .13 9.0 (2) 18.0 (4) .50

Abbreviations: EFV, efavirenz; NVP, nevirapine; RNase H, ribonuclease H.